Natural History of Patients With PH3 and a History of Stone Events
NCT04542590
·
clinicaltrials.gov ↗
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Hyperoxaluria Type 3
Sponsor
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company